These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice. Born JL; Hadley WM Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598 [TBL] [Abstract][Full Text] [Related]
29. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors. Wong KH; Wallen CA; Wheeler KT Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188 [TBL] [Abstract][Full Text] [Related]
30. The role of glycolysis and hexose monophosphate pathway in the hypoxic toxicity of misonidazole. De Groot H; Ling LL; Sutherland RM Free Radic Res Commun; 1987; 3(1-5):93-8. PubMed ID: 3508447 [TBL] [Abstract][Full Text] [Related]
31. Changes in misonidazole binding with hypoxic fraction in mouse tumors. Hirst DG; Hazlehurst JL; Brown JM Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291 [TBL] [Abstract][Full Text] [Related]
32. Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia. Hoffman JM; Rasey JS; Spence AM; Shaw DW; Krohn KA Stroke; 1987; 18(1):168-76. PubMed ID: 3810750 [TBL] [Abstract][Full Text] [Related]
33. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro. Taylor YC; Rauth AM Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314 [TBL] [Abstract][Full Text] [Related]
34. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors. Wong KH; Zhang H; Wallen CA; Wheeler KT Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675 [TBL] [Abstract][Full Text] [Related]
35. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro. Shrieve DC; Denekamp J; Minchinton AI Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545 [TBL] [Abstract][Full Text] [Related]
36. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Franko AJ; Koch CJ; Garrecht BM; Sharplin J; Hughes D Cancer Res; 1987 Oct; 47(20):5367-76. PubMed ID: 3652041 [TBL] [Abstract][Full Text] [Related]
37. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice. MacManus MP; Maxwell AP; Abram WP; Bridges JM Br J Cancer; 1989 Mar; 59(3):349-52. PubMed ID: 2930698 [TBL] [Abstract][Full Text] [Related]
38. Comparison between the binding of [3H]misonidazole and AF-2 in Chinese hamster V79 spheroids. Olive PL; Rasey JS; Durand RE Radiat Res; 1986 Jan; 105(1):105-14. PubMed ID: 3945722 [TBL] [Abstract][Full Text] [Related]
39. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers. Koch CJ; Giandomenico AR; Iyengar CW Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345 [TBL] [Abstract][Full Text] [Related]